Classes
Publications
- Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma-data from the Czech registry2012 | First Faculty of Medicine
- Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma2012 | First Faculty of Medicine
- Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database2012 | First Faculty of Medicine
- Prognostic and predictive factors in metastatic renal cell cancer treated with targeted therapies2011 | First Faculty of Medicine
- Metastatic Renal Cell Carcinoma Treated with Everolimus – Data from the RENIS Clinical Registry2011 | First Faculty of Medicine
- Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma2024 | Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine
- Sperm mitochondria dysfunction in response to testicular cancer2024 | First Faculty of Medicine, Faculty of Science
- Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy2024 | Publication without faculty affiliation
- Klinická onkologie2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine
Loading network view...